Moderna puts Kenya plant plans on hold

According to a statement unveiled Thursday (Apr. 11), Moderna has not received any vaccine orders for the continent since 2022 and has faced the cancellation of previous orders, resulting in more than $1 billion in losses and write-downs.

Continue reading on AfricaNews...